Modern techniques of separating and collecting the different components found in blood as well as pathogen inactivation of blood components, have led the area of Haematology to new treatments and more efficient use of donate blood.
The company is actively involved in supplying the latest technology in this field ,superior products, building long term relationships and a strong commitment to after sales service and product support.
TerumoBCT is a worldwide leader with tradition in innovation in the areas of Hemapheresis and blood component management.
It also holds a leading position in the Greek market in the areas of plateletpheresis, therapeutic plasma exchange as well as therapeutic cell collection.
From 2006 TerumoBCT has entered the area of blood component processing with the introduction of unique systems to simplify and automate whole blood processing as well as a novel pathogen reduction system to help improve the safety of the blood supply by reducing the infectious levels of disease-causing agents in platelets and plasma while still maintaining quality blood components.
Rontis Hellas, with this new cooperation and the development of this new business unit, would be actively involved in supplying the latest technology in the Greek market in the areas of Hemapheresis and Blood bank through superior scientific and technical support.